Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies
Miller Fisher syndrome (MFS) is a subtype of Guillain-Barr é syndrome (GBS) which is characterized by the three components of ophthalmoplegia, ataxia, and areflexia. Some studies reported MFS as an adverse effe...
Source: BMC Neurology - Category: Neurology Authors: Dorsa Alijanzadeh, Afsaneh Soltani, Fatemeh Afra, Fardis Salmanpour, Amir Hossein Loghman, Noosha Samieefar and Nima Rezaei Tags: Research Source Type: research
More News: Ataxia | Brain | Covid Vaccine | COVID-19 | Guillain-Barr Syndrome | Neurology | Opthalmology | Study | Vaccines